EP Patent

EP1785420A1 — Thiazole analogues and uses thereof

Assigned to 4SC AG · Expires 2007-05-16 · 19y expired

What this patent protects

The present invention relates to compounds of the general formula (I) and salts and physiologically functional derivatives thereof, R 2 is attached at the 4- or 5-position of the thiazole ring and is hydrogen, alkyl, halogen, cyano, alkoxy, haloalkyloxy, or alkylamino; …

USPTO Abstract

The present invention relates to compounds of the general formula (I) and salts and physiologically functional derivatives thereof, R 2 is attached at the 4- or 5-position of the thiazole ring and is hydrogen, alkyl, halogen, cyano, alkoxy, haloalkyloxy, or alkylamino; X independently represents a divalent linkage group selected from S, O, NR 4 , SO, or SO 2 ; R 4 is hydrogen, alkyl, cycloalkyl, cycloalkylalkyl, or heterocyclyl; is attached at the 4- or 5-position of the thiazole ring and independently represents one of the following groups of the general formula (II): wherein the dotted line represents a single or double bond; * indicates the point of attachment to the thiazole ring; n is 1,2, or 3.

Drugs covered by this patent

Patent Metadata

Patent number
EP1785420A1
Jurisdiction
EP
Classification
—
Expires
2007-05-16
Drug substance claim
No
Drug product claim
No
Assignee
4SC AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.